Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
434,676
-
Shares change
-
+434,676
-
Total reported value, excl. options
-
$392,000
-
Value change
-
+$392,000
-
Number of buys
-
9
-
Price
-
$0.9028
Significant Holders of iBio, Inc. - Common Stock (IBIO) as of Q2 2018
9 filings reported holding IBIO - iBio, Inc. - Common Stock as of Q2 2018.
iBio, Inc. - Common Stock (IBIO) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 434,676 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (179,440 shares), SIGNATUREFD, LLC (152,910 shares), GEODE CAPITAL MANAGEMENT, LLC (34,266 shares), BlackRock Inc. (16,205 shares), NORTHERN TRUST CORP (14,328 shares), HighTower Advisors, LLC (13,502 shares), PANAGORA ASSET MANAGEMENT INC (13,380 shares), UBS Group AG (8,645 shares), ROYAL BANK OF CANADA (2,000 shares), and MORGAN STANLEY (1,450 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.